Connect with us:

Facebook Twitter RSS

News & Updates

18 Jun 2014

Role for an experienced scientist available at the Curie Institute

The Curie Institute is a world-class multidisciplinary cancer center comprising a dedicated cancer Hospital and a prestigious Research Center with expertise in biology, genetics, soft matter physics, organic and medicinal chemistry. The Curie Institute benefits from state-of-the-art technical platforms as well as a large clinical data base and patient sample collection.

The Curie Institute is seeking an experienced scientist (post doctorate plus 4 years’ experience) to coordinate and develop the disseminated disease biomarker activity in the translational research department.

Numerous projects are ongoing at the Institute to measure circulating tumour cells in the blood (2 Veridex machines are available) or bone-marrow of patients with diverse cancers at different disease stages. Measurement of circulating tumour DNA has been implemented for ocular melanoma patients and other solid tumours using innovative techniques or deep sequencing.

The scientist chosen will be responsible for the coordination of these projects on disseminated tumour disease detection: comparison of techniques, benchmarking and development of novel approaches and evaluation of large scale cohorts of patients for the clinical interest of these new markers. Functional and/or genetic studies may be envisioned on the isolated circulating tumour cells. The scientist will interact with the medical oncologists implicated in this translational research, as well as researchers from Chemistry, Physics, Genetics and Cellular biology groups currently involved in this project.

The Institut Curie is attractively located in central Paris, in close proximity to the other major Parisian research centers.

The applicant should have a solid knowledge of cancer biology, expertise in cellular and molecular techniques, and a good publication record in related fields of biology with an interest in new assay development. The applicant must have demonstrated the ability to obtain competitive funding, as it will be necessary to apply for external funding to support this project. S(H)e will coordinate a team  consisting of 3 technicians, 2 post-docs and a part-time clinical research assistant, located in the hospital on the Institut Curie Paris campus. Strong interpersonal skills are necessary to interact with the various clinicians and biologists implicated to date.

Please send your application including CV, 3 letters of recommendation and a 3-5 page scientific project to Sergio Roman-Roman and Jean-Yves Pierga ( ;

Deadline August 31st 2014

More publications

14 Dec 2016: Preserving fertility in girls and young women with cancer “haphazard” say experts 23 Dec 2015: 'Hematological Malignancies: from Mechanisms to Therapy' symposium - March 9/12, 2016 - Milan 02 Dec 2015: European cancer centres finally united in long-term collaborative partnerships 19 Nov 2015: SiRIC-Curie Call for translational research group leaders, Paris, France 20 Oct 2015: IARC Fellowships for Cancer Research 03 Aug 2015: Optimizing sharing of hospital biobank samples: new EurocanPlatform paper published in Science Translational Medicine 17 Jul 2015: 3rd EurocanPlatform Summer School in Translational Cancer Research: Portugal, 12 – 16 October 2015 17 Jul 2015: NCT Heidelberg School of Oncology Fellowship Program in Translational Cancer Research - Call for applications 01 Jul 2015: EurocanPlatform project engages directly with patient groups at ECPC AGM 19 Jun 2015: EurocanPlatform Translational Research Course 12th - 16th October - Save the Date! 13 May 2015: Catch up on all the latest from the EurocanPlatform project in the May 2015 Newsletter 14 Apr 2015: New EurocanPlatform paper published in PLOS One 31 Mar 2015: Launch of personalised medicine survey: Literacy among healthcare professionals 30 Mar 2015: OECI Cancer Days 2015 in Porto, Portugal 10 Mar 2015: Workshop on circulating biomarkers in cancer 19 Feb 2015: Meeting report from the second EurocanPlatform summer school on translational cancer research published in ecancermedicalscience 27 Jan 2015: The January 2015 Newsletter is here! 21 Jan 2015: Most types of cancer not due to “bad luck”, says IARC 06 Jan 2015: Brand new videos available from the 2nd Translational Research Course 08 Dec 2014: New conference report for the EurocanPlatform Chemoprevention Meeting published in ecancermedicalscience 20 Nov 2014: The November 2014 Newsletter is here! 13 Nov 2014: IARC/WHO Fellowships 05 Nov 2014: Research course on circulating tumor cells (CTC) at the Karolinska Institute 28 Oct 2014: Eighth Belgian Symposium on the Integration of Molecular Biology Advances into Oncology Clinical Practice 03 Oct 2014: Core values for a new cancer culture: six centres create Cancer Core Europe 01 Sep 2014: EurocanPlatform paper published in the Journal of Oncology Practice 18 Aug 2014: 4th Annual meeting of EurocanPlatform project, October 25-26th 2014 04 Aug 2014: EurocanPlatform Translational Cancer Research Summer Course, Portugal, October 20-24, 2014 31 Jul 2014: The Summer 2014 Newsletter is here! 20 May 2014: New science policy paper published in Molecular Oncology 19 Feb 2014: Workshop on "Tissue-based Biomarkers for Advancement of Personalized Cancer Treatment" 21 Jan 2014: The second Advanced Lecture Course on Translational Cancer Research 21 Jan 2014: OECI and ECPC - How Uniform Is Cancer Care? February 18th 2014 31 Oct 2013: FDA pulls ponatinib approval due to blood clots and narrowing of blood vessels 22 Oct 2013: Publications from within EurocanPlatform - Year 2 09 Oct 2013: IARC: Postdoctoral fellowships for training in cancer research 12 Sep 2013: VHIO-Fritz Bender Foundation joint International Symposium 13 Aug 2013: HPV vaccine could also prevent oropharyngeal cancer, says IARC 13 Aug 2013: New ECPC Board of Directors 11 Jun 2013: EAPM Members Update: Discussion on the Data Protection Legislation 21 May 2013: Growing call to abandon impact factors 29 Apr 2013: New partnership between IARC and CRI to spur cancer research in Thailand and across South-East Asia 11 Apr 2013: OECI 2013 Oncology Days - including EurocanPlatform Session 08 Mar 2013: Spreading the cancer prevention message in Sierra Leone 25 Feb 2013: EAPM: Access to health data is essential for the development of new treatments 20 Feb 2013: Access to health data is essential for the development of new treatments, says European Alliance of Personalised Medicine 23 Jan 2013: Course in cancer genomics at EBI 26 Oct 2012: Scientists discover potential new 'roots' of breast cancer 19 Sep 2012: Personalised medicine promises radical improvements to healthcare in Europe